Source: The American Journal of Dermatopathology. Unidades: SVOI, FMRP
Subjects: HIPERSENSIBILIDADE A DROGAS, HANSENÍASE, LINFÓCITOS T, INTERLEUCINAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
VANZELA, Tamara de Nardo et al. Th17 response of borderline-lepromatous leprosy inhibits rash manifestation of Dapsone Hypersensitivity Syndrome: case report. The American Journal of Dermatopathology, v. 40, n. 3, p. 205-208, 2018Tradução . . Disponível em: https://doi.org/10.1097/dad.0000000000000839. Acesso em: 02 nov. 2024.APA
Vanzela, T. de N., Bernardes Filho, F., Wambier, C. G., Faria, F. M., Foss, N. T., & Frade, M. A. C. (2018). Th17 response of borderline-lepromatous leprosy inhibits rash manifestation of Dapsone Hypersensitivity Syndrome: case report. The American Journal of Dermatopathology, 40( 3), 205-208. doi:10.1097/dad.0000000000000839NLM
Vanzela T de N, Bernardes Filho F, Wambier CG, Faria FM, Foss NT, Frade MAC. Th17 response of borderline-lepromatous leprosy inhibits rash manifestation of Dapsone Hypersensitivity Syndrome: case report [Internet]. The American Journal of Dermatopathology. 2018 ; 40( 3): 205-208.[citado 2024 nov. 02 ] Available from: https://doi.org/10.1097/dad.0000000000000839Vancouver
Vanzela T de N, Bernardes Filho F, Wambier CG, Faria FM, Foss NT, Frade MAC. Th17 response of borderline-lepromatous leprosy inhibits rash manifestation of Dapsone Hypersensitivity Syndrome: case report [Internet]. The American Journal of Dermatopathology. 2018 ; 40( 3): 205-208.[citado 2024 nov. 02 ] Available from: https://doi.org/10.1097/dad.0000000000000839
